C6461003 AN, INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED, STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH METASTATIC COLORECTAL CANCER



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Cancer Partners of Nebraska, Lincoln, NE location

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*